• Why Rigel Pharmaceuticals Stock Is Jumping Today

    Shares of Rigel Pharmaceuticals (NASDAQ: RIGL) were jumping 10.3% as of 12:30 p.m. EST. The gain came after Rigel and Eli Lilly (NYSE: LLY) announced a collaboration to develop and market Rigel’s experimental drug R552.
    Rigel will receive an up-front payment of $125 million from Lilly under the new agreement. In addition, Rigel could be eligible for milestone payments of up to $835 million. The company will also receive tiered royalties from any future sales of R552, ranging from the mid-single digits to the high teens.
    Image source: Getty Images.
    Continue reading

    Join the Discussion

    Your email address will not be published. Required fields are marked *

    Back to top